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Targeted expression profiling reveals
distinct stages of early canine fibroblast
reprogramming are regulated by 2oxoglutarate hydroxylases
Ian C. Tobias1,2, Mian-Mian C. Kao1, Thomas Parmentier3, Hailey Hunter1, Jonathan LaMarre3 and
Dean H. Betts1,4*

Abstract
Background: Ectopic expression of a defined set of transcription factors allows the reprogramming of mammalian
somatic cells to pluripotency. Despite continuous progress in primate and rodent reprogramming, limited attention
has been paid to cell reprogramming in domestic and companion species. Previous studies attempting to reprogram
canine cells have mostly assessed a small number of presumptive canine induced pluripotent stem cell (iPSC) lines for
generic pluripotency attributes. However, why canine cell reprogramming remains extremely inefficient is poorly
understood.
Methods: To better characterize the initial steps of pluripotency induction in canine somatic cells, we optimized
an experimental system where canine fetal fibroblasts (cFFs) are transduced with the Yamanaka reprogramming
factors by Sendai virus vectors. We use quantitative PCR arrays to measure the expression of 80 target genes at
various stages of canine cell reprogramming. We ask how cFF reprogramming is influenced by small molecules
affecting the epigenomic modification 5-hydroxymethylcytosine, specifically L-ascorbic acid and retinoic acid (AA/
RA).
Results: We found that the expression and catalytic output of a class of 2-oxoglutarate-dependent (2-OG) hydroxylases,
known as ten-eleven translocation (TET) enzymes, can be modulated in canine cells treated with AA/RA. We further show
that AA/RA treatment induces TET1 expression and facilitates early canine reprogramming, evidenced by upregulation of
epithelial and pluripotency markers. Using a chemical inhibitor of 2-OG hydroxylases, we demonstrate that 2-OG hydroxylase
activity regulates the expression of a subset of genes involved in mesenchymal-to-epithelial transition (MET)
and pluripotency in early canine reprogramming. We identify a set of transcription factors depleted in
maturing reprogramming intermediates compared to pluripotent canine embryonic stem cells.
(Continued on next page)
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Conclusions: Our findings highlight 2-OG hydroxylases have evolutionarily conserved and divergent functions
regulating the early reprogramming of canine somatic cells and show reprogramming conditions can be
rationally optimized for the generation of maturing canine iPSC.
Keywords: Reprogramming, Pluripotent, Mesenchymal-to-epithelial transition, Canine, DNA hydroxymethylation,
TET dioxygenase, 2-Oxoglutarate-dependent hydroxylase, Ascorbic acid, Retinoic acid, Embryonic stem cell

Background
Domestic dogs are susceptible to a variety of inherited
and acquired diseases with analogous conditions in human patients [1, 2]. Multiple factors have likely contributed to these shared pathologies including exposure to
common environmental mutagens and toxins during
human-canine coexistence [3], as well as similarities in
immune system anatomy and development [4]. Due to
these clinical similarities and even shared genetic etiology identified with comparative genomics, the dog has
emerged as a powerful model to understand human genetic diseases [5–7]. Modeling the effect of diseaseassociated genetic variants in an assortment of cell types
has been made feasible by the overexpression of a defined set of factors to generate induced pluripotent stem
cells (iPSCs) [8, 9]. Ectopic expression of human or murine orthologues of the transcription factors OCT4,
SOX2, KLF4, and MYC (OSKM) have been reported to
generate putative canine iPSC lines [10–13]. However,
the routine use of canine iPSCs has been limited by a
lack of standardized canine reprogramming protocols
and has led to inconsistent use of various reagents and
donor somatic cells [14]. Moreover, few clonal canine
iPSC lines have been established [15, 16] and no quantitative evidence of long-term canine iPSC self-renewal
has been reported. Studies of several putative canine
iPSC lines have revealed unique features compared to
human iPSC such as the requirement of exogenous
leukemia inhibitor factor (LIF) in addition to fibroblast
growth factor 2 (FGF2) for proliferation in the undifferentiated state [11, 15]. Reprogramming canine fibroblasts with integrating vectors is reported to be a highly
protracted process, ranging from 30 to 40 days [17]. Yet
the molecular events during canine reprogramming have
been neither characterized nor temporally defined. An
understanding of the bottlenecks in canine somatic cell
reprogramming is critical to improving the probability of
successful reprogramming and mapping the molecular
events during canine pluripotency acquisition.
As reprogramming cell transition towards the induced
pluripotent state, distinct molecular events occur at defined timepoints that broadly segment reprogramming
into initiation, maturation, and stabilization phases [18–
20]. Global analyses of epigenetic modifications in
reprogramming intermediates suggest that direct

reprogramming to pluripotency is constrained by
nuclear determinants controlling the redistribution of
repressive chromatin modifications [21, 22]. iPSC derivation experiments and computational modeling indicate
reprogramming transcription factors bind previously silent regulatory sequences to facilitate local epigenetic remodeling and activate gene transcription, including
critical pluripotency regulators [23, 24]. Targeted genomic DNA demethylation during iPSC generation and
maintenance of hypomethylated chromatin in pluripotent cells are mediated by the ten-eleven translocation
(TET) family of methylcytosine dioxygenase enzymes
[25, 26]. TET enzymes require 2-oxoglutarate (2-OG) to
mediate DNA demethylation through the oxidation of 5methylcytosine (5-mC) into a variety of cytosine substituents, which are then recognized by base-excision repair
machinery [27, 28].
The longest-lived product of TET catalysis is 5hydroxymethylcytosine (5-hmC) [29]. 5-hmC shows genomewide overlap with OCT4 and NANOG motifs as well as histone modifications indicative of regulatory elements [30].
TET recruitment by reprogramming factors or by indirect effectors are thought to lead to active demethylation, particularly at enhancers and promoters, prior to chromatin opening
and transcriptional activation [31]. At least one competent
TET paralogue is required for the successful acquisition of
pluripotency by mouse somatic cell reprogramming [32]. The
importance of active demethylation is underscored in a
mouse embryonic fibroblast (MEF) reprogramming model
lacking the base-excision repair pathway component thymine
DNA glycosylase, rendering cells incapable of reprogramming
due to an impediment to epigenetic activation of miRNA
clusters crucial to mesenchymal-to-epithelial transition
(MET) [32].
Several endogenously produced small molecules regulate TET abundance, catalytic activity, and/or recruitment such as alpha-ketoglutarate [33], L-ascorbic acid
(vitamin C) [34, 35], and retinoic acid (a derivative of
vitamin A) [36, 37]. L-ascorbic acid has been reported to
improve the kinetics of both mouse and human somatic
cell reprogramming, which suggests an evolutionarily
conserved role in direct reprogramming to pluripotency
[38, 39]. Moreover, retinoic acid signaling is required for
reprogramming to a naïve pluripotent state in mice [40].
It is conceivable that TET proteins may participate in
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active DNA demethylation, or otherwise enable more
permissive histone modifications by cross-regulatory
mechanisms, at regulatory elements for key determinants of pluripotency during canine somatic cell reprogramming. However, the soluble factors controlling TET
abundance and activity in a somatic nuclear environment and how they could be leveraged in reprogramming canine cells have yet to be explored. Taking
advantage of the non-integrating CytoTune-iPS 2.0 Sendai virus gene-delivery system, which are designed as
self-limiting and non-transmissible [41, 42], we investigated whether modifiers of DNA methylation could promote early canine reprogramming. We highlight that
initiation of canine fetal fibroblast reprogramming exhibits features of MET. Both the MET-like transcriptional response and early pluripotency gene upregulation
can be bolstered by L-ascorbic acid and retinoic acid at
concentrations that enhance TET-mediated 5-hmC generation. Although barriers to canine iPSC maturation
still exist, we define a subset of pluripotency-associated
transcription factors enriched at the transcript level in
canine embryonic stem cells (cESCs) that may promote
the acquisition of stable pluripotency in canine cells.

Materials and methods
Fibroblast and embryonic stem cell culture

Cryovials of primary canine adult fibroblasts at passage 2
(T0269) were purchased from Applied Biological Materials Inc. (Vancouver, Canada). Additionally, cryovials of
passage 1 or 2 canine fetal fibroblasts derived from
mixed-breed beagles were a gift from Dr. Jeong YeonWoo of Sooam Biotech Research Foundation (Seoul,
South Korea) [43]. Adult or fetal canine fibroblasts were
maintained in high-glucose DMEM supplemented with
10% Gibco™ qualified, Canada-origin fetal bovine serum
(FBS), 2 mM GlutaMax, 1X non-essential amino acids,
and 0.1 mM 2-mercaptoethanol. MEF monolayer preparation and culture of canine ESCs were conducted as previously described [44, 45]. Briefly, E12.5 DR4 MEFs
obtained from Applied StemCell (CA, USA) were mitotically arrested by γ-irradiation and seeded at 1.5 × 104
cells/cm2 for ESC co-culture. Canine ESC (cESC) lines
derived at the Ontario Veterinary College from embryo
explants (EX2, EX5, and EX7) were seeded onto γirradiated MEFs in a medium composed of KnockOut
DMEM/F12, 15% KnockOut Serum Replacement, 1X
GlutaMax, 1X non-essential amino acids, 0.1 mM 2mercaptoethanol, 10 ng/mL human LIF, and 4 ng/mL
human FGF2. Maintenance cultures of cESCs were
propagated by picking and mechanically dissociating individual colonies into fragments. Canine partially reprogrammed (cPR) cell lines were maintained in MEFconditioned cESC medium and split every 4–5 days with
TrypLE Express enzyme. Incubators were maintained at
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37 °C, 5% CO2, and ambient oxygen. Unless otherwise
stated, all cell culture reagents were obtained from
Thermo Fisher Scientific.
Somatic cell reprogramming

Two days prior to transduction, canine fibroblasts were
seeded at 5 × 104 cells per well of a six-well plate. Using
the CytoTune-iPS 2.0 Reprogramming Kit (Thermo
Fisher Scientific), Sendai viral vectors (SeV) encoding
human KOS (KLF4/OCT4/SOX2), c-MYC, and KLF4
were added to individual wells containing 2–2.5 × 105
cells according to the manufacturer’s protocol with some
modifications. The multiplicity of infection (MOI) for
KOS and c-MYC SeV vectors were adjusted to six (an
average of six viral particles per cell) and the KLF4-SeV
vector MOI was increased from three to five, based on
transduction efficiencies achieved using CytoTune
emGFP reporter (Thermo Fisher Scientific).
For experimental manipulation of early canine reprogramming, fibroblast medium was supplemented with
100 μM ascorbic acid and 0.1 nM retinoic acid (AA/RA)
or an equivalent volume of diluent (vehicle) beginning
2 days post-infection (DPI). Treatments were applied
with daily medium exchanges for 4 days. At 6 DPI, the
transduced cells were bulk passaged and transferred (3–
5 × 104 cells) to 10-cm culture dishes containing 2 × 104/
cm2 γ-irradiated CF1 MEFs (Applied Stem Cell). For
analysis of 6 DPI intermediates, 0.8 × 106 cells were
pelleted, submerged in RNAlater (Sigma Aldrich), and
stored at − 80 °C until nucleic acid extraction. Presumptive canine iPSC colonies were maintained in basal
medium containing KnockOut DMEM/F12 containing
15% KnockOut Serum Replacement (KOSR) [45, 46] or
high-glucose DMEM with 10% FBS. Co-cultures of
transduced canine fibroblasts and γ-irradiated MEFs
were visually monitored for focal epithelialization and
the emergence of primary colonies. For clonal isolation
(10–20 DPI), primary colonies were mechanically isolated with a pipet tip and transferred into Geltrex- and
MEF-coated (25,000 MEF/well) 48-well plates. For analysis of 10 DPI intermediates, 50–70 primary colonies
were mechanically isolated by with a pipet tip and submerged in RNAlater for storage at − 80 °C.
RT-qPCR and quantification of relative transcript
abundance

Total RNA from cultured cells was isolated using PureLink RNA kit (Thermo Fisher) and quantified using a
NanoDrop spectrophotometer. One microgram of total
RNA was treated with RQ1 DNase (Promega) and used
to synthesize cDNA using the Superscript II Reverse
Transcription kit (Thermo Fisher) with 1.25 μM each of
oligo dT and random hexamers. qPCR reaction mixtures
contained 5-μL SensiFast SYBR (BioLine), 1 μL primer
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mixture (500 nm final), and 2 μL cDNA template. PCR
assays were run on using the CFX384 Real-Time System
(BIO-RAD). Annealing temperatures were optimized
for the amplification of a single product of expected
size, excised, and sequenced at the London Regional
Genomics Center to confirm specificity. All custom
primer sequences and annealing temperatures can be
found in Supplemental Table 1. Reaction data were
corrected for individual primer amplification efficiencies, calculated from a dilution series standard. The
expression ratio for genes of interest was normalized
to two reference genes (TBP and RPS5) and calculated using the delta-delta Ct method.
For the RT2 Profiler PCR array, 400 ng of DNasetreated RNA was reverse transcribed to cDNA using the
RT2 First Strand Kit (Qiagen). Quantitative PCR was
performed using the Canine Epithelial-Mesenchymal
Transcription RT2 Profiler PCR Array (Qiagen) according to the manufacturer’s guidelines. Alternatively, the
expression of the canine homologues of reprogrammingassociated genes were measured with a custom RT2 Profiler PCR Array (Qiagen). All transcripts targeted with
the custom RT2 Profiler PCR Array are listed in Supplemental Table 2. Data generated from the qPCR arrays
was analyzed as expression ratios using sets of five reference genes. For the RT2 Profiler PCR Array Dog
Epithelial-Mesenchymal Transition (PAFD-090Z), the
reference genes used were ACTB, B2M, GAPDH,
HPRT1, and RPLP1. For the RT2 Profiler PCR Array
Custom Dog Reprogramming (CAPF14050), the reference genes used were GAPDH, HPRT1, RPLP1, PPIA,
and TBP. Among transcripts targeted by the custom dog
reprogramming PCR array, only LIN28B, NR5A2, and
LEFTY1 were not detected and excluded from further
analysis.
Targeted bisulfite-PCR and promoter methylation analysis

Genomic DNA from cultured cells was isolated using
GenElute Mammalian Genomic DNA Miniprep kit
(Sigma Aldrich). Genomic DNA was eluted in nucleasefree water, and sample concentrations were determined
using NanoDrop spectroscopy (Thermo Fisher Scientific). Bisulfite modification and purification was performed using the EZ DNA Methylation Gold kit (Zymo
Research) with 400 ng of genomic DNA. Bisulfiteconverted DNA was used immediately for PCR using
Platinum Taq Polymerase and primer pairs designed to
target the 5′-flanking sequences close to the transcriptional start site of canine POU5F1 and NANOG [15]
(Supplemental Table 3). Nested re-PCR was performed
with 3 μL of the resultant bisulfite-PCR reaction mixture.
PCR amplifications used variations of the following thermal cycling protocol: 3 min at 94 °C; 35 cycles of 94 °C
for 20 s, 59–64 °C gradient for 15 s, 72 °C for 15 s; 72 °C
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for 5 min final extension. In nested re-PCR reactions, a
touchdown annealing range of 70–64 °C was added before amplification cycles.
PCR amplicons were ligated into pCR2.1 plasmids
and transformed into competent E. coli using the TA
cloning kit (Thermo Fisher). Bacteria were spread
onto LB agar and grown overnight in a 37 °C bacterial
incubator. Clones were picked, transferred into LB
medium with ampicillin, and grown in suspension for
16 h. The plasmid DNA were purified with Presto
Mini Plasmid kit (Frogga Bio) and sequenced at the
London Regional Genomics Centre (Robarts Research
Institute, London, ON) with 3730 DNA Analyzer System (Applied Biosciences). Base calls, quality trimming, and vector clipping were performed using preGap and Gap4 (Staden Package) [47]. To determine
accurate methylation patterns on target regions, at
least 10 processed clone sequences were aligned to
the reference genomic sequence for each biological
replicate using the R/Bioconductor package methVisual [48]. The methylation state for each CpG site
was exported from the quality-checked aligned sample
sequences. For each acceptable clone, we adjusted the
cytosine methylation level based on the bisulfite conversion rate (Biscon) with each bisulfite-PCR reaction:
Adjusted
Methylation
Level
 Cytosine

.
C meth
Biscon
¼
C total
Immunolabeling for fluorescence microscopy and flow
cytometry

For fluorescence microscopy, cells were stained for 1
h with CD44-PE (IM7; 12-0441-82; 1:100 dilution) or
CD90-PE (YKIX337.217; 12-5900-42; 1:50 dilution) diluted in a 3% BSA staining solution. Cells were imaged on the stage of a Leica DMI 6000B microscope.
Digital images were captured with an Orca Flash
camera (Hamamatsu Photonics) and Application Suite
X software (Leica Microsystems). Brightness and contrast were standardized to isotype stained samples,
and the equivalent imaging parameters were applied
to all other images using ImageJ (National Institutes
of Health, MD).
For flow cytometry, cells were first collected by a
cell scraper after treating with enzyme-free cell dissociation buffer containing EDTA for 5 min and further dissociated with TrypLE enzyme for 6 min at
37 °C. Single live cells in suspension were filtered
through a 70-μm strainer adjusted to a density of approximately 106 cells/mL in staining buffer (1% bovine serum albumin, 0.075% sodium azide) and
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incubated with CD90-PE (1:50 dilution), CD44-PE (1:
100 dilution), or an isotype control for 1 h protected
from light. Cells were washed twice with staining buffer and stained with 7-aminoactinomycin D reagent
to exclude dead cells. Events were recorded using the
Accuri C6 platform (BD Bioscience) using the standard laser configuration and the following optical filters: 533/30, 585/40, 670 LP, and 675/25. Single color
or fluorescence minus one control samples containing
an equivalent volume of diluent were included to set
analysis gates and to threshold background autofluorescence. Samples stained with the IgG isotype control (12-4031-82) were used to determine non-specific
antibody binding. All antibodies were obtained from
Thermo Fisher Scientific.
5-Methylcytosine and 5-hydroxymethylcytosine
quantification

Genomic DNA was isolated as described above (see
the “Targeted bisulfite-PCR and promoter methylation
analysis” section), aliquoted, and diluted to 10 ng/μL.
Global 5-methylcytosine or 5-hydroxymethylcytosine
levels were assessed from 75 to 150 ng of total gDNA
using 5-mC DNA ELISA Kit or Quest 5-hmC DNA
ELISA Kit (Zymo Research), according to the manufacturers’ recommendations. Briefly, percent 5-mC or
5-hmC was interpolated from a five-point standard
curve and adjusted based on the CpG dinucleotide
density of the reference genome assembly for the species under investigation.
Statistical analysis

Sample sizes and statistical method specific to each figure are denoted in figure legends. All statistical analyses
and plotting were performed using R statistical software
(version 3.5.0, The R Foundation for Statistical Computing, Vienna, Austria). A P value less than 0.05 was considered statistically significant. Experiments were not
randomized, and no statistical method was used to predetermine sample size. When two groups were compared, an unpaired t test or, if assumptions of normality
and homoscedasticity were violated, a Mann-Whitney
test was performed. For multiple group comparisons, either one-way analyses of variance (ANOVA) or the nonparametric Welch’s ANOVA was applied. A two-way
ANOVA was performed on datasets with two grouping
variables. Where significance existed for a grouping factor, Tukey or Dunn post hoc methods were carried out
to determine significant differences between group
means. For correlation analyses, the linear association
between RT2 Profiler qPCR array expression datasets
was computed using the non-parametric Kendall rank
correlation coefficient. Principal component analysis was
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performed using the PCAtools package, and heatmaps
were generated using the pheatmap package [49, 50].

Results
Adult canine fibroblasts are refractory to transcription
factor-mediated reprogramming

Limited progress has been reported in canine cellular
reprogramming, in contrast to the rapid acceleration
of iPSC technologies in primates and rodents. Moreover, the contribution of numerous cellular pathways
or molecular processes, such as DNA methylation, as
barriers to canine pluripotency induction and maintenance has yet to be explored. We established canine
partially reprogrammed (cPR) cell lines in a previous
attempt to reprogram canine adult fibroblasts (cAFs)
with the CytoTune-iPS Sendai vectors. Interestingly,
cPR lines could be scaled for greater than 20 passages
in feeder-free culture with MEF-conditioned cESC
medium (KOSR/LIF/FGF2) permitting the derivation
of clonal lines from independent transductions. However, the cPR lines produce heterogeneous cultures
consisting of colonies with compact centers and include cells positive for SSEA4, a marker of pluripotent cESCs [45], surrounded by cells with bipolar
morphology (Supplemental Figure 1A). We explored
to what extent cPR clones achieve promoter demethylation and expression of core pluripotency transcription factors. RT-qPCR analyses show that cPR clones
have greater expression of the canine POUF51/OCT4
homologue compared to adult fibroblasts (Supplemental Figure 1B, P < 8.82 × 10−3). However, the transcript
abundances for NANOG were not different compared
to adult fibroblasts (P > 0.61), and SOX2 was only significantly upregulated in the cPR-L6 line (Supplemental Figure 1B, P = 9.81 × 10−4).
7To investigate the extent of pluripotency gene silencing, the methylation of the status of the promoter regions
of canine NANOG and POU5F1 was assessed in cPR cells
and parental cAFs compared to cESCs. Different CpG
methylation profiles were observed in the NANOG promoter and the POU5F1 promoter between cAF, cPR, and
primed type (LIF-FGF2) cESCs (Supplemental Figure 1C).
The overall methylation level of the NANOG promoter
region was lower in cESC compared to both cAF (P =
1.25 × 10−3) and cPR (P = 6.36 × 10−4) (Supplemental Figure 1D). Additionally, the degree of POU5F1 promoter
methylation is lower in cESC compared to cAF (P =
0.032), but not cPR cells (P = 0.082) (Supplemental Figure 1E). These findings suggest that the triad of core pluripotency transcription factors are incompletely expressed
in cPR clones. Moreover, cAFs were observed to be refractory to reprogramming by exogenous transcription factors
as only partially reprogrammed clones exhibiting a methylated NANOG promoter could be attained.
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Canine fetal fibroblasts have greater TET expression, 5hmC level, and proliferation rate compared to adult
fibroblasts

We reasoned that primary canine fibroblasts derived
from less mature donor tissues may undergo reprogramming towards pluripotency more efficiently, which has
been linked to both proliferative capacity and various
nuclear determinants of the undifferentiated state [51,
52]. Canine fetal fibroblasts (cFFs) reported to be permissive to somatic cell nuclear transfer-mediated reprogramming [43] were assessed for their suitability as
donor cells for OSKM transcription factor-mediated reprogramming. Fluorescent immunocytochemistry and
flow cytometry revealed positive staining for mesenchymal surface antigens CD90/THY1 and CD44 [53, 54] on
greater than 98% cultured cFFs (Fig. 1A, B, Supplemental Figure 2A). Early passage cFF cells also exhibited a
more rapid proliferation rate compared to early passage
cAFs (Supplemental Figure 2B-C, P = 0.038). Manipulation of genomic DNA methylation via de novo methyltransferase or TET dioxygenase enzymes have been
effective strategies to increase the probability of
complete reprogramming in both rodent and primate
cells [55–57]. We analyzed both 5-mC and 5-hmC levels
by DNA ELISA to determine if the degree of global cytosine methylation or cytosine hydroxymethylation differs
among primary fibroblasts from adult or fetal donor tissues, cPR cells, and pluripotent cESCs. We observed that
the percent of 5-methylcytosine did not significantly differ across cAF, cFFs, cPR cells, or cESCs (Fig. 1C). Basal
5-hmC was not significantly different between cFF and
cAF (P = 0.98), and both fibroblast populations exhibit
lower 5-hmC (~ 150-fold) compared to cESCs (P < 1 ×
10−7) and cPR cells (Fig. 1D, P < 1 × 10−7). However,
relative transcript abundance was significantly greater
for the canine TET1 (Fig. 1E, P = 4.2 × 10−2), TET2
(Fig. 1F, P = 3.4 × 10−2), and TET3 (Fig. 1G, P = 9.0 ×
10−3) in fetal compared to adult canine fibroblasts.
These results suggest that canine somatic cells derived
from less mature donor tissue exhibit greater abundances of TET paralogues, but maintain similar levels of
cytosine modifications genome wide.
Combined ascorbic acid and retinoic acid treatment
facilitates mesenchymal-to-epithelial transition in early
canine reprogramming

To investigate the role of canine TET paralogues in canine somatic cell reprogramming, we used small molecule supplementation as a strategy to manipulate
reprogramming progression without genetic interventions. The enzymatic activity of TET enzymes is activated by exogenous cofactors or inhibited by structural
analogues, both of which are broadly available and inexpensive [58]. We initially sought to profile pan-TET
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activity and TET paralogue expression in canine somatic
cells upon exposure to combinations of RA and AA at
concentrations applied to human or mouse iPSC generation [38, 59]. Using the ratio of genome-wide 5-hmC to
5-mC as an index of the overall catalytic output of TET
enzymes [60], we observed both AA (Fig. 2A, F = 4.08,
P = 2.83 × 10−2) and RA (Fig. 2A, F = 6.73, P = 4.26 ×
10−3) have a significant independent contribution on the
observed 5-hmC to 5-mC ratio in cFFs. Only 100 μM
AA (Fig. 2A, P = 0.033) and 0.1 nM RA (Fig. 2A, P =
0.035) significantly elevated 5-hmC to 5-mC ratio compared to vehicle controls. Exposure of canine fibroblast
to various RA concentrations did not alter TET paralogue expression (Supplemental Figure 2D-F), whereas significant changes in canine TET1 (Supplemental Figure
2D, P = 0.0171) and TET3 (Supplemental Figure 2F, P =
6.29 × 10−3) abundance were only detected at 250 μM
AA conditions compared to vehicle control. Collectively,
these results suggest that combinatorial exposure to
100 μM AA and 0.1 nM RA increases 5-hmC level relative to 5-mC, independent of changes to TET paralogue
expression.
How genes associated with reprogramming to a pluripotent state are regulated in transcription factormediated reprogramming from canine somatic cells is
still unknown. To fill this gap, we leveraged the nonintegrating Sendai virus (SeV) reprogramming platform
(CytoTune-iPS 2.0 Kit), designed to reprogram human
somatic cells and reported to reprogram murine fibroblasts to deliver the human OSKM homologues to cFFs
[41]. Based on transduction efficiencies observed with
the control SeV-eGFP vector, we transduced cFF cultures at less than 20% confluency with SeV particles at
multiplicity of infection (MOI) values of at least five
(Supplemental Figure 2G-H). Only cFF transductants
treated with AA/RA produced focal cell clusters with
epithelial character by 4 DPI with observable increases
in size and frequency by 5 to 6 DPI (Fig. 2B). Interestingly, we observe that AA/RA-treated cells exhibit
greater expression of TET1 (Fig. 2C, P = 1.80 × 10−2), but
neither TET2 (Fig. 2D, P = 0.72) nor TET3 (Fig. 2E, P =
0.96). In addition, reprogramming intermediates exposed
to AA/RA generate primary colonies more frequently
upon re-seeding onto MEF feeders compared to vehicletreated controls (Fig. 2F, P = 2.86 × 10−2).
We next examined the abundance of transcripts associated with mesenchymal or epithelial cell identity in 6 DPI
reprogramming intermediates by the qPCR array. Correlation analysis and hierarchical clustering revealed that targeted expression profiles of biological replicates both
grouped together and were highly similar (Kendall’s tau
coefficient τ > 0.94), suggesting that merging data across
arrays was robust to batch effects (Fig. 3A). This analysis
also highlighted that AA/RA-treated intermediates were
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Fig. 1 Cell type-dependent levels of 5-methylcytosine and 5-hydroxymethylcytosine. a Representative fluorescent micrographs for canine fetal fibroblasts (cFFs)
stained with phycoerythin (PE)-conjugated antibodies against CD44 and CD90/THY1. Scale bar unit length is 50 μm. b Overlay histograms showing cFFs stained
with PE-conjugated antibodies (red) or isotype control antibodies (black). Fold difference in c 5-methylcytosine and d 5-hydroxymethylcyctosine levels in canine
adult fibroblast (cAF), canine fetal fibroblast (cFF), canine partially reprogrammed (cPR), and canine embryonic stem cells (cESCs). Data are presented as mean ±
standard error, n = 4. Relative transcript abundance for e TET1, f TET2, and g TET3 in steady-state cultures of cAF and cFF. Data are presented as mean ±
standard error, n = 3. Means annotated with different letters are considered significantly different by one-way analysis of variance and Tukey’s honestly squared
difference test, P < 0.05

more dissimilar to non-transduced cFF cells than vehicletreated intermediates at 6 DPI. The transcripts of several
DNA-binding proteins involved in the repression of epithelial gene expression were downregulated in 6 DPI reprogramming intermediates compared to cFF cultures

that did not receive SeV reprogramming factors (SNAI2,
ZEB1) (Fig. 3B, P < 8.63 × 10−3). Furthermore, SMAD2
transcript was significantly decreased in AA/RA intermediates compared to transductants receiving only vehicle
diluent (Fig. 3B, P = 1.08 × 10−2). Similarly, 6 DPI
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Fig. 2 L-ascorbic acid and retinoic acid modulates 5-hmC level and promotes focal epithelialization in early canine reprogramming of TET paralogue
expression. a 5-hmC to 5-mC ratio in canine fetal fibroblasts (cFFs) cultured in atmospheric oxygen and exposed to various concentrations of Lascorbic acid (AA) and/or retinoic acid (RA). Each data point is calculated from paired aliquots from the same purified gDNA sample and analyzed by
separate ELISA assay kits. b Representative phase-contrast micrographs of cFFs transduced with CytoTune-iPS 2.0 Sendai Reprogramming Kit (SeV 6:5:6)
at 4 or 5 days post-infection (DPI). Transductants were treated with L-ascorbic acid and retinoic acid (AA/RA) or an equivalent volume of diluent (VEH).
Yellow dashed outlines delimit areas of focal epithelial cluster formation exclusively in the AA/RA-treated transductants. Relative transcript abundance
for c TET1, d TET2, and e TET3 in steady-state cFF, transduced cFF treated with VEH, or AA/RA. F Summarization of the primary colony counts (per 105
transduced cells) performed 4 days after re-seeding on mouse embryonic fibroblast feeder cells (10 DPI). Data are presented as mean ± standard error,
n = 3. Means annotated with different letters are considered significantly different by two-way analysis of variance or the two-sample Mann-Whitney
test, P < 0.05. Scale bars are 250 μm

intermediates exhibited a lower abundance of several
mesenchyme-associated transcripts that encode secreted
proteins (FN1, BMP2, SERPINE1) compared to parental
cFF cells (Fig. 3C, P = 1.99 × 10−2). Among three mammalian transforming growth factor beta (TGFβ) isoforms,
only TGFβ1 was significantly decreased in AA/RA intermediates relative to vehicle control (Fig. 3C, P = 4.28 ×
10−2). Strikingly, several transcripts related to cytoskeletal
(MSN, MAP1B, KRT7) and plasma membrane (F11R,
TMEFF2) components were differentially abundant in reprogramming intermediates compared to donor cFF cells
(Fig. 3D, E, P < 1.30 × 10−2). Notably, mesodermal markers
CDH2 (P = 4.51 × 10−2) and VIM (P = 3.55 × 10−2) were
significantly lower in AA/RA-treated intermediates compared to the vehicle group (Fig. 3D), whereas hallmark
transcripts of epithelial cell types including CDH1 (P =
2.31 × 10−3), DSP (P = 6.54 × 10−3), KRT14 (P = 2.43 ×
10−3), and KRT19 (P = 1.72 × 10−2) were significantly elevated in AA/RA reprogramming intermediates compared
to vehicle-treated transductants (Fig. 3E). Together, these
findings indicate that AA/RA supplementation during the
early reprogramming of canine fibroblasts can facilitate a
transcriptional response resembling mesenchymal-toepithelial transition (MET).
Targeted expression profiling of canine reprogramming
intermediates identifies genes controlled by 2oxoglutarate-dependent hydroxylase activity

We asked if genes associated with canine cell reprogramming are regulated by 2-oxyglutarate-dependent (2OG) hydroxylases including epigenetic modifiers such as
the TET paralogues. The contribution of pan-TET enzymatic activity in AA/RA reprogramming conditions
was assessed using dimethyloxalylglycine (DMOG), a
competitive inhibitor of 2-OG hydroxylase activity [61,
62]. We titrated the concentration of DMOG in cFF culture medium and observed that genome-wide 5-hmC
level decreased in a dose-dependent manner (Supplemental Figure 3A, P = 9.46 × 10−6). Both 100 μM and
300 μM DMOG decreased global 5-hmC (Supplemental
Figure 3A, P = 1.58 × 10−3) and did not significantly
affect population doubling intervals compared to
vehicle-treated cFF (Supplemental Figure 3B, P = 0.57).

Notably, reprogramming progression could not be reproducibly assessed by alkaline phosphatase staining due
to high endogenous levels of the enzyme in bulk transductants and heterogenous colony staining at the 10 DPI
timepoint (Supplemental Figure 3C-D).
To gain a view of transcriptional regulation in early canine reprogramming, we carried out targeted expression
profiling of reprogramming-associated transcripts in
three biological replicates of intermediate cell populations by qPCR arrays (Fig. 4a). Hierarchical clustering
showed that 6 DPI transductants exposed to AA/RA are
less similar to vehicle-treated cells than transductants
with the DMOG/AA/RA treatment (Fig. 4b). Principal
component analysis revealed that cFFs harvested at 0
DPI were different from the three groups of 6 DPI cells
infected with the Yamanaka reprogramming factors
(Fig. 4c). Among 6 DPI samples, AA/RA-treated reprogramming intermediates least resembled 0 DPI cFFs.
Ten DPI reprogramming intermediates were different
from samples collected at 6 DPI as well as pluripotent
cESC cultures. Signaling proteins (STAT3, SMAD1,
BMPR1A) and transcription factors (DPPA5, NANOG,
SALL4) involved in early embryonic development contribute to PC1 (52.88% of variation), which distinguishes
cESC samples from cFFs and reprogramming intermediates (Supplemental Figure 3E). Biological replicates correlated well (Kendall’s tau coefficient τ > 0.91),
particularly the collection of 6 DPI samples representing
heterogenous populations in the early phase of reprogramming (Fig. 4d). Compared to vehicle-treated 6 DPI
transductants, we detected a greater number of differentially expressed genes in reprogramming intermediates
receiving AA/RA than those concomitantly exposed to
DMOG (42 vs. 25) (Fig. 4e). The influence of DMOG/
AA/RA treatment, based on the number of differentially
expressed genes compared to cells receiving only AA/
RA, is more pronounced in 6 DPI transductants than in
primary colonies harvested at 10 DPI (37 vs. 16) (Fig. 4f).
Nevertheless, we observe an overlap of several DMOGsensitive transcripts (CDC42, EZH2, IL6ST, NR0B1,
STAT3, ST3GAL2, TGFB1) which remain differentially
expressed in 10 DPI samples. These findings indicate
that exposure to AA/RA for a defined period in early

Tobias et al. Stem Cell Research & Therapy

(2020) 11:528

Page 10 of 23

Fig. 3 L-ascorbic acid and retinoic acid enhance a transcriptional response resembling mesenchymal-to-epithelial transition. a Heatmap of Pearson
correlation coefficients of transcript panel abundances in each sample and grouped by hierarchical clustering. b Relative abundances of transcripts
associated with regulation of gene expression. c Relative abundances of transcripts associated with secreted ligands or matrix components. d Relative
abundances of transcripts associated with the cytoskeleton or cell adhesion that are downregulated at 6 DPI. e Relative abundances of transcripts
associated with the cytoskeleton or cell adhesion that are upregulated at 6 DPI. Data are presented as mean ± standard error, n = 3. Means annotated
with different letters are considered significantly different by one-way analysis of variance and Tukey’s honestly squared difference test, P < 0.05
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Fig. 4 Exploratory data analysis and summarization of differential gene expression for targeted expression profiles of canine reprogramming
intermediates. a Schematic of canine fetal fibroblast (cFF) reprogramming and timepoints of RNA sample collection. b Hierarchical clustering
analysis of all samples based on gene expression. c Principal component analysis of all samples based on gene expression. d Correlation heatmap
of all samples based on gene expression. Sequential color scale represents Kendall’s rank correlation coefficient. e Venn diagram showing the
number of differentially expressed genes versus the 6 DPI vehicle (VEH) group for 6 DPI AA/RA (red) and 6 DPI DMOG/AA/RA (blue). f Venn
diagram showing the number of differentially expressed genes for AA/RA versus the corresponding DMOG/AA/RA group at 6 DPI (red) and 10
DPI (blue)

reprogramming alters the expression of numerous
DNA-binding, chromatin-binding, and signaling factors
associated with the acquisition of pluripotency.
To parse sets of genes whose expression in early canine reprogramming are sensitive to AA/RA supplementation or DMOG-mediated inhibition of 2-OG
hydroxylases, we performed a more focused hierarchical
clustering analysis to highlight specific relationships
among gene expression patterns in 6 DPI samples
(Fig. 5A). Cluster 1 identified transcripts induced by
AA/RA exposure and partially abrogated by DMOG cosupplementation. Cluster 2 identified transcripts that
were de-repressed in DMOG samples compared to AA/
RA- or vehicle-treated transductants. Examples of gene
products grouping into cluster 2 include those belonging
to the TGFβ signaling pathway (ACVR1B, SMAD3,
TGFB2, TGFBR1). Clusters 3 and 4 both identified transcripts that are suppressed by AA/RA treatment and
generally insensitive to DMOG co-supplementation.
Notably, clusters 3 and 4 were composed of WNT signaling pathway components (FZD7, CTNNB1, TCF3)
and transcripts indicative of fibroblast-like cell populations (VIM, MSN, THY1, CD44).
Consistent with and building on our results for MET
transcript panels, all epithelial markers profiled grouped
in cluster 1. Both CDH1 (P = 4.09 × 10−2) and EPCAM
(P = 1.84 × 10−2) were significantly elevated in AA/RA 6
DPI cultures compared to transductants co-supplemented
with DMOG (Fig. 5B), whereas THY1 was significantly
lower in the AA/RA group compared to both samples receiving DMOG/AA/RA or vehicle (Fig. 5B, P < 1.05 ×
10−3). Interestingly, collections of transcripts also grouping
into cluster 1 include pluripotency-associated transcription factors (NR0B1, ESRRB, KLF4, SALL4, NANOG),
components of the LIF signaling pathway (LIFR, IL6ST,
STAT3), and cell proliferation markers (CCNA2, CCNE1,
CDC42, MYC). Among general markers of pluripotency,
POU5F1 transcript abundance was significantly lower in
the presence of DMOG (Fig. 5C, P < 1.29 × 10−3). Both
NANOG and KLF4 transcript levels were significantly
greater in 6 DPI transductants exposed to AA/RA compared to the vehicle group (Fig. 5C, P = 1.97 × 10−4 and
P = 1.43 × 10−2). SOX2 and LIN28A expression were not
affected by AA/RA, with or without DMOG, compared to
6 DPI intermediates receiving vehicle (Fig. 5C, P = 0.12).

At this timepoint, both AA/RA and DMOG/AA/RA cultures exhibit lower expression of the enzyme ALPL
(Fig. 5C, P = 2.17 × 10−3 and P = 2.70 × 10−2). Several transcription factors enriched in early embryonic cells and reflective of naïve transcriptional circuitry [63] are
significantly more abundant in AA/RA transductants
compared to 6 DPI cells treated with DMOG/AA/RA including ESRRB (P = 2.91 × 10−2), GBX2 (P = 1.04 × 10−2),
KLF5 (P = 2.25 × 10−2), NR0B1 (P = 3.20 × 10−2), and
SALL4 (Fig. 5D, P = 6.50 × 10−6). These findings are consistent with our expectation that the expression of a subset
of pluripotency-associated transcription factors is facilitated by AA/RA treatment and at least partially abrogated
by DMOG exposure.
Genes associated with the LIF signaling pathway such
as LIFR (P = 5.03 × 10−3), IL6ST (P = 3.16 × 10−2), STAT3
(P = 6.52 × 10−3), and SOC3 (P = 4.51 × 10−2) were differentially expressed in early reprogramming intermediates
supplemented with AA/RA compared to samples exposed to vehicle diluent or DMOG/AA/RA (Fig. 5E).
Moreover, DMOG co-treatment was associated with decreased transcript levels for the proliferation-associated
genes MYC (P = 1.81 × 10−2), CCNE1 (P = 2.21 × 10−3),
CCNA2 (P = 1.32 × 10−2), and CDC42 (P = 8.13 × 10−8)
but not MYCN (P = 0.69) when compared to cells receiving AA/RA alone (Fig. 5F). We also observed that multiple genes associated with TGFβ signaling including
SMAD2 (P = 5.04 × 10−3), SMAD3 (P = 4.32 × 10−3),
TGFB2 (P = 6.90 × 10−4), and TGFBR1 (P = 3.65 × 10−3)
showed greater expression in samples allocated the
DMOG/AA/RA treatment compared to the AA/RA condition (Fig. 5G). Overall, these results support the notion
that 2-OG hydroxylase activity, either directly or indirectly, contributes to the regulation of cell proliferation
as well as the LIF-STAT3 and TGFβ-SMAD2/3 signaling
pathways in early canine reprogramming.
Targeted expression profiling of canine embryonic stem
cells and reprogramming intermediates distinguishes
pluripotent cell-specific gene signatures

We next concentrated on the primary colonies derived
from the AA/RA or DMOG/AA/RA treatment groups
collected at 10 DPI and again used hierarchical clustering to assess relationships between gene expression patterns in the maturation phase of canine reprogramming
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Fig. 5 AA/RA medium supplementation in early canine reprogramming facilitates the upregulation of a subset of transcripts associated with pluripotency,
proliferation, and LIF signaling. a Hierarchical cluster analysis to identify subsets of genes that show specific expression patterns across specific samples of early
(6 DPI) canine reprogramming intermediates. Divergent color scale represents gene expression scaled by row. b Relative abundances of transcripts associated
with cell surface proteins or the synthesis of cell surface antigens. c Relative abundances of transcripts associated with cell pluripotency. d Relative abundances
of transcripts associated with early embryonic (naïve) pluripotency. e Relative abundances of transcripts associated with leukemia inhibitory factor (LIF)-signal
transducer and activator of transcription 3 (STAT3) signaling. f Relative abundances of transcripts associated with cell proliferation. g Relative abundances of
transcripts associated with transforming growth factor beta (TGFβ) signaling. Data are presented as mean ± standard error, n = 3. Means annotated with
different letters are considered significantly different by one-way analysis of variance and Tukey’s honestly squared difference test, P < 0.05

(Fig. 6A). Cluster 1 included a small set of co-expressed
genes enriched in 10 DPI reprogramming intermediates.
Notably, the transcription factor POU3F1/OCT6, which
is expressed in the epiblast and anterior neural plate
[64], exhibited greater expression in maturing primary
colonies compared to parental cFFs or cESCs (Supplemental Figure 3F, P < 3.02 × 10−4 and P < 4.67 × 10−4).
Clusters 2 and 3 pinpointed genes associated with general cell proliferation and the fibroblast phenotype. Clusters 4 identified a large subset of transcripts enriched in
cESCs that are also expressed in 10 DPI AA/RA colonies
(FOXD3, ESRRB, LIN28A, TBXT), while genes grouping
in cluster 5 exhibited an cESC-specific expression pattern (TBX3, KLF4, POU5F1, NANOG).
The primary colonies of reprogramming intermediates
harvested at 10 DPI display similar expression patterns
among the genes assessed in either the presence or absence of DMOG, with a few exceptions. Reprogramming
intermediates from the 10 DPI AA/RA group showed
significantly greater abundance of the LIN28A and
NR0B1 transcripts compared to the 10 DPI DMOG/AA/
RA colonies (Fig. 6B, C, P = 4.13 × 10−2 and P = 2.35 ×
10−2). AA/RA colonies also showed a greater level of
ST3GAL2 expression (Fig. 6D, P = 4.42 × 10−4), a sialyltransferase protein that produces the stage-specific embryonic antigen 4 (SSEA4) glycolipid [65]. Consistent
with our findings in 6 DPI transductants, primary colonies that received DMOG treatment showed lower relative abundances of IL6ST and STAT3 transcripts
(Fig. 6E, P = 8.13 × 10−3 and P = 2.55 × 10−2). Three enzymes involved with chromatin modifications or remodeling and linked to gene transactivation, specifically
KDM6A (P = 0.97), SMARCA4/BRG1 (P = 0.48), and
WDR5 (P = 0.41), did not significantly differ between
AA/RA and DMOG/AA/RA colonies (Fig. 6F). Conversely, we observe DMOG supplementation is associated with decreased expression of the core polycomb
repression complex 2 (PRC2)-associated proteins EED
(P = 1.82 × 10−2) and EZH2 (P = 9.40 × 10−6) [66], compared to reprogramming intermediates treated with AA/
RA alone (Fig. 6G). Collectively, these results indicate
that transient exposure of canine reprogramming intermediates to AA/RA induces few latent changes in the
expression of genes related to pluripotency, LIF

signaling, and PRC2 components, which are mitigated
by chemical antagonism of 2-OG hydroxylase activity.
To propagate maturing ciPSCs, we attempted singleand bulk-colony passaging techniques in different
growth factor combinations (Fig. 7A). Culture medium
composed of 10% FBS and DMEM was the most effective at facilitating primary colony formation between 7
and 10 DPI, which was accentuated with exogenous LIF
supplementation (Fig. 7A). However, maturing ciPSCs
progressively lost compact border morphology and gradually formed monolayer structures with radial asymmetry (Fig. 7B). Canine reprogramming intermediates
could not be maintained beyond 3 weeks of reprogramming. At this time point, SeV-derived transcripts are not
differentially abundant compared to non-transduced
cFFs (Fig. 7C). Our differential gene expression analyses
revealed that 20 of 24 pluripotency-associated transcription factors assessed by qPCR array displayed greater expression levels in cESCs when compared to either AA/
RA or DMOG/AA/RA 10 DPI reprogramming intermediates (Fig. 6B, C and Supplemental Figure 3G-H, P <
0.05). We tested gene-gene correlations in cESCs and 10
DPI reprogramming intermediates to discern genes
which do not have a common expression pattern
(Fig. 7D, E). Comparisons of primary colonies exposed
to AA/RA to cESC showed an overall positive correlation, but also that subsets of cell-cell adhesion proteins
and transcription factors (e.g., SALL4, TBX3, SOX2)
contribute to dissimilarity (Fig. 7D). Furthermore, this
analysis underscored that disparities in gene expression
between AA/RA-derived primary colonies and cESC
samples were shared with cells from the DMOG/AA/RA
condition (Fig. 7E). We reasoned that gene products involved in transcriptional regulation contribute to cell
identity and derived a network from the 27 genes with
DNA-binding or chromatin-binding functions and coexpressed in cESCs using GeneMANIA (Fig. 7F) [67].
The network analysis separated KDM6A and SMAD5
from a pluripotency sub-network consisting of transcription factors and epigenetic modifiers (Fig. 7F). Relatively
dense interconnections between CTNNB1, SOX2, and
SALL4 indicate that WNT/β-catenin signaling may have
an important role in maintaining the pluripotent stem
cell phenotype of cESCs (Fig. 7F). Together, these results
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Fig. 6 Primary colonies derived from transductants exposed to AA/RA exhibit few differentially expressed genes compared to DMOG/AA/RA colonies.
a Hierarchical cluster analysis to identify subsets of genes that show specific expression patterns across specific samples of canine fetal fibroblasts (cFF;
labeled 0 DPI), maturing (10 DPI) canine reprogramming intermediates, and cESC. Divergent color scale represents gene expression scaled by row.
b Relative abundances of transcripts associated with cell pluripotency. c Relative abundances of transcripts associated with early embryonic (naïve)
pluripotency. d Relative abundances of transcripts associated with cell surface proteins or the synthesis of cell surface antigens. e Relative abundances
of transcripts associated with leukemia inhibitory factor (LIF)-signal transducer and activator of transcription 3 (STAT3) signaling. f Relative abundances
of transcripts associated with chromatin-modifying or remodeling enzymes involved in the activation of gene transcription. g Relative abundances of
transcripts associated with chromatin-modifying or remodeling enzymes involved in the repression of gene transcription. Data are presented as
mean ± standard error, n = 3. Means annotated with different letters are considered significantly different by one-way analysis of variance and Tukey’s
honestly squared difference test, P < 0.05

suggest that 10 DPI reprogramming intermediates have
not acquired a stable pluripotent state akin to cESCs.
Furthermore, sustained re-expression of a network of
transcriptional regulators that are enriched in cESCs
during canine iPSC maturation may depend on alternative signaling pathways to LIF/STAT3.

Discussion
It is currently unknown if canine reprogramming mirrors
the trajectory of human or mouse cells towards the iPSC
state. Previous studies have focused on the molecular
characteristics and differentiation potential of a limited
number of putative canine iPSC clones derived from a single reprogramming experiment [16, 68]. These studies do
not consider the discrete phases of somatic cell reprogramming and lacked a physiological pluripotent cell type,
such as cESCs, to provide a reference transcriptional signature for a canine pluripotent stem cell. To improve the
reproducibility of canine iPSC derivation, it is essential to
identify potentially obstructive mechanisms to the reprogramming of canine cells by forced expression of transcription factors. Our targeted gene expression and DNA
methylation assays indicate that partially reprogrammed
cells derived from adult fibroblasts exhibit limited pluripotency factor expression, methylation of the NANOG promoter, and lower 5-hmC levels compared to cESC lines.
We focused on gene regulation in early cFF reprogramming at timepoints with visible epithelial change among
the bulk transductants and characterized a transcriptional
response resembling MET. We determined that the initiation of cFF reprogramming, inferred from morphological
and transcriptional features associated with MET, is
amenable to reinforcement by AA/RA treatment, which
modulate 5-hmC accumulation in canine fibroblasts. To
our knowledge, this represents the first hypothesis-driven
approach to improve the initiation of canine reprogramming with Sendai-based reprogramming vectors. Using
SeV-transduced cFFs as a model to study early canine reprogramming, we identified reprogramming-associated
genes responsive to AA/RA and/or DMOG, which indicate these loci may be regulated by 2-OG hydroxylases
such as the TET paralogues. Lastly, we define a set of
DNA- or chromatin-binding proteins from targeted gene

expression profiling, which are depleted in reprogramming intermediates compared to pluripotent cESCs, as
candidate positive regulators of canine somatic cell reprogramming (Fig. 8).
Comparisons of time-resolved data from reprogramming models using different cell types and/or species
have identified context-specific trajectories and barriers
to acquired pluripotency [69, 70]. We observed incomplete demethylation of the NANOG promoter region,
and as a plausible consequence, endogenous NANOG
transcripts were not upregulated in cPR clones. Limited
endogenous pluripotency gene re-activation and constrained epigenetic remodeling is also evident in porcine
reprogramming, a Laurasiatherian species like domestic
dogs [71]. We found that endogenous POU5F1 expression in cPR lines does not correlate well with the methylation status of the − 394 to − 88 POU5F1 promoter
region assessed in this study. However, high CpG content promoters like the canine POU5F1 locus may
instead be under the regulator control of chromatinmodifying complexes [72]. Endogenous POU5F1 expression is indispensable for iPSC stabilization and maintenance of pluripotency [73]. Additionally, we made two
key observations regarding the dynamics of endogenous
POU5F1 expression in canine reprogramming. First, incompletely reprogrammed cPR lines stably re-express
POU5F1 in a nuclear context where SOX2 and NANOG
transcripts are not upregulated compared to donor cAF
cultures. Second, POU5F1 transcript levels are lower in
6 DPI transductants exposed to 2-OG hydroxylase antagonist DMOG. Based on these findings, we posit that
POU5F1 re-expression dynamics resemble the human
reprogramming time course, wherein POU5F1 is reversibly re-expressed during MET, as opposed to during the
later maturation phase in murine reprogramming [74,
75]. Species-specific mechanisms contributing to endogenous POU5F1 activation upon ectopic OSKM expression may be partly responsible for the different
latencies observed in the reprogramming mouse (~ 20
days) or human (~ 30 days) somatic cells.
For nuclear reprogramming to occur during iPSC generation, thousands of loci gain or lose DNA methylation
[19] as reprogramming factors direct active DNA
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Fig. 7 Canine reprogramming intermediates are depleted of a subset of pluripotency-associated factors expressed in cESC. a Summarization of raw
counts of primary colonies emerging in the first 4 days after passaging transduced cFFs (7–10 DPI) in medium containing FBS. b Representative phasecontrast micrograph of one serially pick-passaged primary colony on (I) 10 DPI, (II) 14 DPI, (III) 18 DPI, (IV) 22 DPI, (V) 26 DPI, and (VI) 30 DPI. c Relative
transcript abundance (Log10 transformed) of SeV-derived transcripts encoding KLF, KLF-OCT4-SOX2 (KOS), and MYC. Data are presented as mean ±
standard error, n = 3. Means annotated with different letters are considered significantly different by one-way analysis of variance Tukey’s honestly
squared difference test, P < 0.05. d Scatterplot of Log2-scaled expression ratios for a representative cESC sample versus a representative 10 DPI AA/RA
sample. e Scatterplot of Log2-scaled expression ratios for a representative cESC sample versus a representative 10 DPI DMOG/AA/RA sample. Blue dots
represent genes contributing to dissimilarity in the overall positive gene-gene association. f GeneMANIA network where nodes represent top
differentially expressed genes in ESC versus 10 DPI primary colonies (AA/RA and DMOG/AA/RA groups). Edges represent known genetic interactions
(green) or co-expression (purple) between genes based on datasets compiled by GeneMANIA. Densely interconnected nodes are shaded gray

demethylation mechanisms [31] and outcompete the
somatic gene regulatory network to allow de novo DNA
methylation of lineage-associated genes [76]. Higher reprogramming efficiencies between somatic cell types
positively correlate with a number of hypermethylated
tissue-specific genes shared with pluripotent ESCs [77].
Embryonic and fetal cell populations are often more efficiently reprogrammed, occasionally with fewer ectopic
transcription factors expressed, compared to differentiated adult cells [78, 79]. We found no differences in the
prevalence of 5-mC between adult or fetal canine fibroblasts, cPR cells, or cESCs. This finding is in line with
observations that genome-wide methylation in the established pluripotent cells is similar to somatic cells unless
small molecular inhibitors or activators are added to
drive further epigenome erasure [80, 81]. However,
genome-wide 5-hmC level was greater in cESCs and cPR
cells which are considered more plastic than somatic fibroblasts. We detected greater expression levels of each

mammalian TET paralogue in cFF compared to cAFs. In
addition to dynamically regulating DNA methylation at
regulatory elements, TET enzymes help maintain the
hypomethylated state of high CpG density regions in
pluripotent stem cells [82, 83]. TET1/Tet1 loss-offunction reduces reprogramming efficiency from both
mouse and human somatic cells but is compatible with
successful reprogramming due to functional compensation from TET2/3 [55, 84, 85]. In mouse reprogramming, Tet1 is a direct target of exogenously expressed
Pou5f1 in early reprogramming (days 1–9) and reaches
an expression level similar to mouse ESCs in late reprogramming (days 11–19) [55, 86]. Interestingly, TET2 appears the most important TET paralogue for human B
cell reprogramming [31]. Similarly, we did not observe a
significant induction of canine TET1 under standard reprogramming conditions lacking AA/RA. Moreover, experimental manipulations that increase TET abundance
or catalytic activity promote 5-mC removal and iPSC

Fig. 8 Schematic diagram of L-ascorbic acid and retinoic acid promoting the early reprogramming of canine fibroblasts. AA/RA L-ascorbic acid
and retinoic acid, DMOG dimethyloxalylglycine, TET ten-eleven translocation dioxygenase, MYC myelocytomatosis proto-oncogene, KLF4 Krüppellike factor 4, K-O-S KLF4-OCT4-SOX2
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generation in both human and murine cells [55, 87, 88].
Exogenous Tet1 expression has been reported to increase OSKM-mediated MEF initiation approximately
1.5-fold and could replace Oct4 in the reprogramming
workflow when combined with Sox2, Klf4, and Myc [55].
We observe a 2.7-fold increase in the rate of primary
colony induction accompanied by the activation of an
early subset of pluripotency genes when cFFs transduced
with human OSKM are exposed to AA/RA. However,
without reporter-linked genes to faithfully track reprogramming progress, we expect colony enumeration to be
less discriminative for bona fide canine iPSC emergence.
L-ascorbic acid has been shown to directly interact with
the TET catalytic domain as a cofactor [34, 35] and
enhances Fe(II) recycling [37] to elevate 5-mC hydroxylation activity, whereas retinoic acid is proposed to synergistically increase TET action via nuclear receptor
complex-dependent functions (RAR/RXR) such as upregulation of TET2 and TET3 expression [37] and/or
focal recruitment of TETs and base-excision repair
machinery [36]. Retinoid ligands also have TETindependent mechanisms through NR5A2/LRH1 and
RAR-gamma (RARG) signaling to regulate early human
and mouse reprogramming as well as the induction of
naïve pluripotency-associated genes [59, 89].
The first phase of cell reprogramming is initiation,
which encompasses several of transgene-dependent
events including hyper-proliferation and loss of somatic
cell identity [53]. The specific cellular and molecular
events that define the initiation phase is dependent on
cell type [70] and in fibroblast reprogramming is
highlighted by MET [20, 90]. In our single-infection reprogramming system, we observe altered expression of a
variety of growth factors, adhesion molecules, cytoskeleton components, and transcriptional regulators at 6
DPI, which were consistent with the process of MET.
Interestingly, exposure to AA/RA enhanced several previously established aspects of MET including a switch
from neuronal-type to epithelial-type cadherin expression [91] and the induction of cytokeratin gene expression [92]. In addition to markers of MET, several
transcripts associated with pluripotency, LIF signaling,
and cell proliferation are sensitive to AA/RA and
DMOG. While a certain level of biological variability
and technical noise is expected from these types of comparisons, the observed changes in mRNA abundances
are consistent with the observed cellular phenotypes and
are sensitive to experimental activation or inhibition of
2-oxoglutarate hydroxylases. Our interpretation of these
findings is that these pathways and factors are regulated
at the transcriptional level by 2-OG hydroxylase enzymes in early transcription factor-mediated reprogramming of cFFs. At the time this study was underway,
there were no commercially available chemical inhibitors
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selective for TET catalytic activity, and therefore, we are
not able to rule out the contribution of prolyl hydroxylase enzymes or the Jumonji-C family of lysine demethylases [58]. Transcriptional perturbations to TET
paralogues in combination by TET1/2/3 triple knockdowns in future investigations will clarify the specific
contributions of this family of epigenetic modifiers. The
sampling and analysis of heterogeneous cell populations
is another caveat of the study as the influence of specific
subsets of canine reprogramming intermediates remains
unknown. Cell surface proteins associated with pluripotency are often divergent between species, as observed
for CD90/THY1, CD40, and CD30 when tracking mouse
or human reprogramming, thereby necessitating the empirical identification of these surface markers [76, 93].
As the early transcriptional response to OSKM reprogramming implicates several gene products localized to
the cell surface (CDH1, LIFR, EPCAM), fluorescenceactivated cell sorting and enrichment of cell populations
with epithelial or mesenchymal characteristics will
deconvolute the pathways and processes active in productively reprogramming versus refractory cell populations. Still, observations from bulk transductants in
reprogramming experiments have proven insightful regarding the specific barriers to reprogramming [57, 90],
and the molecular signatures of intermediate reprogramming states have been further refined with single-cell approaches [94]. Other reprogramming vector systems
may yield results that differ from our observations because the trajectory of cell states towards pluripotency
and overall kinetics of iPSC generation is influenced by
the reprogramming system utilized [95]. For instance,
heterogeneity in expression of SeV-derived OSKM is expected to cause differences between the reprogramming
intermediates being studied. Another explanation is that
the transcript markers selected in our assays are biased
towards genes with a known role in pluripotency induction and therefore do not reveal other changes in the
global transcriptome resulting from Sendai reprogramming vector transduction.
Although pluripotency-associated transcription factors
are well-conserved at the amino acid level in vertebrates,
analyses of gene expression patterns and transcription
factor binding sites have revealed extensive rewiring of
transcriptional regulatory interactions [96–98]. Alterations to hierarchical relationships between existing TFs
can lead to divergence in the expression patterns of
orthologous genes and may contribute to speciesspecific determinants in development and reprogramming [96, 99]. Our strategy to stabilize maturing canine
iPSC intermediates in culture media used for routine
culture of canine ESC and putative iPSC was unsuccessful beyond days 26–30 of reprogramming. Fundamental
questions remain outstanding regarding the trophic
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requirements and regulatory processes that achieve a
transgene-independent pluripotent state in the dog. Defining the culture conditions that support the maturation
and prolonged self-renewal of pluripotent cells from
dogs remains an ongoing challenge. We and others have
expanded cESC [45] and ciPSC [15, 100] in culture
medium formulations intended and optimized for human ESC, but we have observed deficiencies in the glycolysis pathway of cESCs cultured in this medium [101].
To date, canine reprogramming studies have only applied small molecule inhibitors to facilitate reprogramming and species-specific determinants of iPSC
derivation are challenging to predict [14]. Herein, we
discerned a subset of factors involved in gene regulation
that are selectively enriched in cESCs compared to actively reprogramming intermediates using a targeted
qPCR profiling assay. We found that the pluripotencyassociated factors DPPA5, NANOG, NR0B1, ZIC3,
SALL4, OTX2, GBX2, and TBX3 distinguish cESCs from
primary colonies at reprogramming day 10. Ectopic expression of these candidate TFs in the OSKM reprogramming workflow is a logical extension of this finding
which may reveal nuclear determinants sufficient for canine iPSC maturation. Interestingly, SALL4, POU5F1,
and OTX2 were differentially expressed in a microarray
study by Chow et al. comparing a candidate canine iPSC
line to iPSC-derived mesenchymal stem cells [16]. The
knowledge of cESC-enriched transcripts that are depleted in reprogramming intermediates will inform new
testable hypotheses for future studies concentrating on
canine iPSC maturation and stabilization.

Conclusions
Our study represents the first investigation to identify
hurdles specific to discrete phases of canine induced
pluripotency. Our examination of early canine reprogramming suggests that MET initiates 4 to 6 days
after cFF transductions with the OSKM transcription
factors. We conclude that 2-OG hydroxylases contribute to the effect of AA/RA culture medium supplementation in early canine reprogramming by
facilitating the transcriptional activation of a subset of
pluripotency factors and developmental signaling
pathway genes. As the barriers to obtaining canine
iPSC remain poorly described, our finding that simple
adaptations to reprogramming media promote the loss
of somatic identity and primary colony formation is a
significant step towards the development of reproducible reprogramming in canine donor cells. This study
also lends support to an evolutionarily conserved TET
regulatory mechanism controlling the MET program,
which has broader implications in the areas of developmental and cancer biology.
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Additional file 1: Supplemental Figure 1. Canine adult fibroblasts
transduced with Sendai virus vectors encoding OSKM generate partially
reprogrammed cell lines. (A) Representative phase-contrast and fluorescent micrographs of a partially reprogrammed clonal cell population
(cPR-L6) staining positive for stage-specific embryonic antigen 4 (SSEA4).
(B) Relative transcript abundance of core pluripotency factors (OCT4,
SOX2, NANOG) and tri-lineage markers (BRACHYURY, GATA6, NESTIN) in
partially reprogrammed (cPR) cell lines and parental adult fibroblast (cAF),
n = 3. (C) Dot plots depict unmethylated (open circle) and methylated
(filled circle) CpG dinucleotides fragments at POU5F1 and NANOG loci in
seven representative technical replicates. Mean adjusted methylation level
for whole promoter fragments at canine (D) NANOG and (E) POU5F1/
OCT4 loci, n = 4. Data are presented as mean ± standard error. Means annotated with different letters are considered significantly different by
one-way analysis of variance and Tukey’s honestly squared difference test,
P < 0.05.
Additional file 2: Supplemental Figure 2. Maturity of donor tissue
influences primary canine fibroblast proliferation and the effect of Lascorbic acid or retinoic acid on TET paralogue transcript level. (A) Isotype
controls for direct immunofluorescence staining of canine fetal fibroblast
(cFF) cultures, related to (i) CD44-PE or (ii) CD90-PE staining experiments
in Fig. 1A. (B) Fold-increase in total cell number over five days of adherent canine adult fibroblasts (cAF) and cFFs. (C) Population doubling time
intervals calculated from linear growth phase in cAF and cFF. (D) Ratio of
5-hydroxymethylcytosine (5-hmC) to 5-methylcytosine (5-mC) in media
containing AA/RA or vehicle diluent. Data are presented as mean ± standard error, n = 4. Relative transcript abundances for (E) cTET1, (F) cTET2 and
(G) cTET3 in canine dermal fibroblasts cultured in atmospheric oxygen
and exposed to various concentrations of AA and/or RA, n = 3. (H) Representative phase-contrast and fluorescent micrographs of canine dermal
fibroblast transduced with emGFP control Sendai vector at various multiplicity of infection (MOI). (I) Summarization of the percent emGFPpositive cells at each MOI determined by flow cytometry. Data are presented as mean n = 2. Means annotated with different letters are considered significantly different by one-way or two-way analysis of variance
and Tukey’s honestly squared difference test, P < 0.05.
Additional file 3: Supplemental Figure 3. Effect of
dimethyloxalylglycine (DMOG) dose escalation on canine fetal fibroblasts
and top-ranking transcripts by component loading and p-values. (A)
Population doubling time intervals calculated from linear growth phase
after 96 h of DMOG treatment. (B) Percent 5-hydroxymethylcytosine calculated after 96 h of DMOG treatment. (C) Relative ALPL transcript abundance in parental cFF cells (0 DPI), bulk transductants at 6 DPI, 10 DPI
primary colonies or canine embryonic stem cells (ESC). (D) Alkaline phosphatase staining visualized by transmitted light microscopy in (I) bulk
transductants evidently without colony formation, (II) primary colonies expressing endogenous pluripotency genes by RT-qPCR, or (III) canine ESC
colonies cultured on mouse embryonic fibroblasts (MEFs). (E) PCA factor
loadings plot displaying the top 2% of transcripts contributing to sample
variance. (F) Maturation barplot for primed pluripotency genes. (G)
Ranked p-value (−Log10 transformed) barplot for AA/RA versus cESC. (H)
Ranked p-value (−Log10 transformed) barplot for DMOG/AA/RA versus
cESC. Data are presented as mean ± standard error, n = 3. Means annotated with different letters are considered significantly different by oneway analysis of variance and Tukey’s honestly squared difference test, P <
0.05.
Additional file 4: Supplemental Table 1. Oligonucleotide primers
used for RT-qPCR. Supplemental Table 2. Oligonucleotide primers used
for bisulfite PCR. *Primer sequences obtained from [15]. Supplemental
Table 3. Transcript targets for custom RT2 Profiler qPCR Array.
Additional file 5. Metadata and normalized values

Abbreviations
iPSC: Induced pluripotent stem cell; OSKM: OCT4 SOX2 KLF4 MYC;
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